BioMarin Pharmaceutical Inc. (BMRN): Price and Financial Metrics
BioMarin Pharmaceutical Inc. (BMRN)
Today's Latest Price: $77.53 USD
1.64 (-2.07%)
Updated Oct 23 4:00pm
Add BMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BMRN Stock Summary
- With a price/earnings ratio of 114.96, Biomarin Pharmaceutical Inc P/E ratio is greater than that of about 92.83% of stocks in our set with positive earnings.
- The price/operating cash flow metric for Biomarin Pharmaceutical Inc is higher than 96.5% of stocks in our set with a positive cash flow.
- In terms of twelve month growth in earnings before interest and taxes, Biomarin Pharmaceutical Inc is reporting a growth rate of -180.67%; that's higher than only 10.4% of US stocks.
- Stocks that are quantitatively similar to BMRN, based on their financial statements, market capitalization, and price volatility, are CREE, ACAD, CERS, PSNL, and JNPR.
- Visit BMRN's SEC page to see the company's official filings. To visit the company's web site, go to www.biomarin.com.
BMRN Stock Price Chart Interactive Chart >
BMRN Price/Volume Stats
| Current price | $77.53 | 52-week high | $131.95 |
| Prev. close | $79.17 | 52-week low | $68.25 |
| Day low | $76.53 | Volume | 1,257,800 |
| Day high | $79.62 | Avg. volume | 1,825,825 |
| 50-day MA | $79.23 | Dividend yield | N/A |
| 200-day MA | $94.46 | Market Cap | 14.06B |
BioMarin Pharmaceutical Inc. (BMRN) Company Bio
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company was founded in 1996 and is based in San Rafael, California.
Loading social stream, please wait...